PL2195645T3 - Metoda wspomagająca diagnostykę i terapię astmy i rak płuc - Google Patents

Metoda wspomagająca diagnostykę i terapię astmy i rak płuc

Info

Publication number
PL2195645T3
PL2195645T3 PL08830503T PL08830503T PL2195645T3 PL 2195645 T3 PL2195645 T3 PL 2195645T3 PL 08830503 T PL08830503 T PL 08830503T PL 08830503 T PL08830503 T PL 08830503T PL 2195645 T3 PL2195645 T3 PL 2195645T3
Authority
PL
Poland
Prior art keywords
aiding
asthma
diagnosis
therapy
lung cancer
Prior art date
Application number
PL08830503T
Other languages
English (en)
Inventor
Robert T Streeper
Elzbieta Izbicka
Sung H Baek
Original Assignee
Cancer Prevention & Cure Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Prevention & Cure Ltd filed Critical Cancer Prevention & Cure Ltd
Publication of PL2195645T3 publication Critical patent/PL2195645T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D59/00—Separation of different isotopes of the same chemical element
    • B01D59/44—Separation by mass spectrography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/62—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating the ionisation of gases, e.g. aerosols; by investigating electric discharges, e.g. emission of cathode
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G01N2800/122—Chronic or obstructive airway disorders, e.g. asthma COPD

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Enzymes And Modification Thereof (AREA)
PL08830503T 2007-09-11 2008-09-11 Metoda wspomagająca diagnostykę i terapię astmy i rak płuc PL2195645T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US97142207P 2007-09-11 2007-09-11
EP20080830503 EP2195645B1 (en) 2007-09-11 2008-09-11 Method for aiding in the diagnosis and therapy of asthma and lung cancer
PCT/US2008/076049 WO2009036193A1 (en) 2007-09-11 2008-09-11 Identification of proteins in human serum indicative of pathologies of human lung tissues

Publications (1)

Publication Number Publication Date
PL2195645T3 true PL2195645T3 (pl) 2014-12-31

Family

ID=40432497

Family Applications (2)

Application Number Title Priority Date Filing Date
PL14161288T PL2781913T3 (pl) 2007-09-11 2008-09-11 Sposób wspomagający diagnostykę i terapię astmy i raka płuca
PL08830503T PL2195645T3 (pl) 2007-09-11 2008-09-11 Metoda wspomagająca diagnostykę i terapię astmy i rak płuc

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL14161288T PL2781913T3 (pl) 2007-09-11 2008-09-11 Sposób wspomagający diagnostykę i terapię astmy i raka płuca

Country Status (11)

Country Link
US (3) US20090069189A1 (pl)
EP (2) EP2781913B1 (pl)
JP (5) JP5592791B2 (pl)
KR (3) KR101541206B1 (pl)
CN (2) CN104297490A (pl)
AU (1) AU2008298888A1 (pl)
CA (1) CA2699296A1 (pl)
ES (2) ES2662846T3 (pl)
HK (1) HK1202619A1 (pl)
PL (2) PL2781913T3 (pl)
WO (1) WO2009036193A1 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8541183B2 (en) 2007-09-11 2013-09-24 Cancer Prevention And Cure, Ltd. Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof
EP3257953B1 (en) 2009-03-12 2018-09-26 Cancer Prevention And Cure, Ltd. Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy
JP5696592B2 (ja) * 2011-06-03 2015-04-08 株式会社島津製作所 質量分析データ解析方法及び解析装置
CA2986730C (en) 2015-05-22 2020-04-14 Expression Pathology, Inc. Srm/mrm assay for the cyclin-dependent kinase inhibitor 2a (p16) protein
CN106596977B (zh) * 2017-02-08 2018-06-08 南京医科大学第一附属医院 ezrin在制备哮喘诊断试剂中的应用
WO2018187496A2 (en) 2017-04-04 2018-10-11 Lung Cancer Proteomics, Llc Plasma based protein profiling for early stage lung cancer prognosis
CN109425647A (zh) * 2017-08-24 2019-03-05 中国科学院大连化学物理研究所 一种蛋白质复合物交联信息深度覆盖的分析方法
CN110398558B (zh) * 2019-07-23 2022-04-01 甘肃农业大学 基于dia技术挖掘性成熟前后藏绵羊睾丸差异蛋白质的方法
CN112798679B (zh) * 2020-10-16 2023-06-20 北京毅新博创生物科技有限公司 用于诊断新冠病毒感染的试剂盒

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998035985A1 (en) * 1997-02-12 1998-08-20 The Regents Of The University Of Michigan Protein markers for lung cancer and use thereof
CA2292788A1 (en) * 1997-06-11 1998-12-17 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
MXPA02007664A (es) * 2000-02-08 2004-08-23 Univ Michigan Separacion y representacion de proteinas.
IL151211A0 (en) * 2000-02-17 2003-04-10 Aventis Pharma Sa Compositions useful for regulating parkin gene activity
WO2002061434A2 (en) * 2001-01-29 2002-08-08 The Center For Blood Research, Inc Anergy-regulated molecules
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
US20030134339A1 (en) * 2002-01-14 2003-07-17 Thomas Brown Proteomics based method for toxicology testing
EP1497658A2 (en) * 2002-04-11 2005-01-19 Oxford GlycoSciences (UK) Ltd Protein involved in cancer
WO2003101283A2 (en) * 2002-06-04 2003-12-11 Incyte Corporation Diagnostics markers for lung cancer
US20060024692A1 (en) * 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
GB0224014D0 (en) * 2002-10-15 2002-11-27 Oxford Glycosciences Uk Ltd A protein involved in therapy
WO2004061410A2 (en) * 2002-12-18 2004-07-22 Ciphergen Biosystems, Inc. Serum biomarkers in lung cancer
EP1735620A4 (en) * 2004-03-30 2008-04-09 Eastern Virginia Med School BIOMARKERS OF LUNG CANCER
GB0508863D0 (en) * 2005-04-29 2005-06-08 Astrazeneca Ab Peptide
US7473530B2 (en) * 2005-05-04 2009-01-06 Wayne State University Method to detect lung cancer
US8053183B2 (en) * 2005-07-27 2011-11-08 Oncotherapy Science, Inc. Method of diagnosing esophageal cancer
EP2485047B1 (en) * 2005-12-22 2016-10-26 Abbott Molecular Inc. Methods and marker combinations for screening for predisposition to lung cancer
JP5131751B2 (ja) * 2005-12-28 2013-01-30 国立大学法人 東京大学 小細胞肺がんの診断のための方法、システムおよび組成物ならびに関連するスクリーニング方法

Also Published As

Publication number Publication date
EP2195645A1 (en) 2010-06-16
CN104297490A (zh) 2015-01-21
EP2195645A4 (en) 2011-08-10
HK1202619A1 (en) 2015-10-02
EP2781913B1 (en) 2017-12-13
KR101645841B1 (ko) 2016-08-04
JP2014098712A (ja) 2014-05-29
EP2781913A2 (en) 2014-09-24
US20180088126A1 (en) 2018-03-29
KR101541206B1 (ko) 2015-08-03
AU2008298888A1 (en) 2009-03-19
KR20150006003A (ko) 2015-01-15
JP2010539486A (ja) 2010-12-16
KR20100100751A (ko) 2010-09-15
WO2009036193A1 (en) 2009-03-19
ES2490165T3 (es) 2014-09-03
CN101836106A (zh) 2010-09-15
KR20160096213A (ko) 2016-08-12
JP2013190440A (ja) 2013-09-26
CA2699296A1 (en) 2009-03-19
PL2781913T3 (pl) 2018-08-31
JP5592791B2 (ja) 2014-09-17
EP2195645B1 (en) 2014-05-07
JP2017049265A (ja) 2017-03-09
US20150126403A1 (en) 2015-05-07
JP2015172591A (ja) 2015-10-01
US20090069189A1 (en) 2009-03-12
ES2662846T3 (es) 2018-04-10
EP2781913A3 (en) 2014-10-15

Similar Documents

Publication Publication Date Title
HK1202619A1 (en) Method for aiding in the diagnosis and therapy of asthma and lung cancer
HK1252674A1 (zh) 在肺癌診斷中的mirna指紋
EP2156184A4 (en) METHOD FOR DIAGNOSIS AND TREATMENT OF PROSTATE AND LUNG CANCER
GB0700560D0 (en) Device and method for the treatment of diseased tissue such as tumours
HK1142908A1 (en) Pyrazinone derivatives and their use in the treatment of lung diseases
HK1136822A1 (en) Therapeutic compounds and their use in cancer
EP2125855A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER OR OTHER DISEASES
EP2214712A4 (en) COMPOSITIONS AND METHODS FOR TREATING ASTHMA AND PULMONARY DISORDERS
HUE037109T2 (hu) Endoxifén rák kezelésében történõ alkalmazásra
EP2142208A4 (en) THERAPY OF NETWORKED BIOPOLYMERS TO REDUCE LUNG VOLUME
EP2340851A4 (en) DIAGNOSTIC METHOD AND THERAPEUTIC METHOD FOR CANCER
EP2171086A4 (en) METHOD FOR THE DIAGNOSIS AND TREATMENT OF CANCER
IL205246A0 (en) Methods and compositions for diagnostic use in cancer patients
EP2190351A4 (en) SYSTEM AND METHODS FOR MEASURING PULMONARY VOLUMES
EP2331711A4 (en) METHOD FOR THE DIAGNOSIS OF CANCER AND DETERMINATION OF THE TOTAL AND NON-DISABLED SURVIVAL PERIOD OF CANCER PATIENTS
EP2144887A4 (en) PHARMACEUTICAL FORMS AND METHOD FOR THE TREATMENT OF CANCER
PL2320900T3 (pl) Opioidy do zastosowania w leczeniu opornych pacjentów onkologicznych
EP2086506A4 (en) PREPARATION OF HEAVY METAL CONTAINING NANO LIPOSOMES AND THEIR USES IN MEDICAL THERAPY
EP2224925A4 (en) COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
ZA200709542B (en) Combination therapy in the treatment of cancer
EP2142648A4 (en) SCREENING AND ANTI-NSCLC THERAPEUTIC METHOD TARGETING THE CDCA8-AURKB COMPLEX
IL226363A0 (en) Compounds and methods for treating cancer
ZA201001876B (en) Treatment of lung cancer
HK1209754A1 (en) Compounds and methods for the treatment of cancer
GB0620067D0 (en) Lung cancer diagnosis and treatment thereof